A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
A Phase 2 study of RTA 402 in Chronic kidney disease (CKD) patients with type 2 diabetes
 mellitus.
To evaluate the efficacy and safety of RTA 402 in patients with type 2 diabetes mellitus.

 To evaluate the safety and tolerability of RTA 402.
Inclusion Criteria:

 -  CKD patients with type 2 diabetes mellitus

 -  Patients whose eGFR levels are eligible for this study

 -  Patients being treated with stable dose of ACE inhibitors and/or ARB etc.

 Exclusion Criteria:

 -  Patients with Type 1 diabetes

 -  Patients with known non-diabetic renal disease

 -  Patients with a history of renal transplantation

 -  Patients with mean SBP > 160 mmHg or mean DBP > 90 mmHg

 -  Patients with HbA1C > 10%

 -  Patients with cardiovascular disease specified in the study protocol etc.